Skip to main content

Thank you for visiting You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

Single-chain variable fragment antibody constructs neutralize measles virus infection in vitro and in vivo

Access options

Rent or Buy article

Get time limited or full article access on ReadCube.


All prices are NET prices.

Fig. 1


  1. 1.

    Durrheim, D. N. et al. A dangerous measles future looms beyond the COVID-19 pandemic. Nat. Med. 27, 360–361 (2021).

  2. 2.

    Hashiguchi, T. et al. Structures of the prefusion form of measles virus fusion protein in complex with inhibitors. Proc. Natl Acad. Sci. USA 115, 2496–2501 (2018).

    CAS  Article  Google Scholar 

  3. 3.

    Tatsuo, H., Ono, N., Tanaka, K. & Yanagi, Y. SLAM (CDw150) is a cellular receptor for measles virus. Nature 406, 893–897 (2000).

    CAS  Article  Google Scholar 

  4. 4.

    Chang, A. & Dutch, R. E. Paramyxovirus fusion and entry: multiple paths to a common end. Viruses 4, 613–636 (2012).

    CAS  Article  Google Scholar 

  5. 5.

    Harrison, S. C. Viral membrane fusion. Nat. Struct. Mol. Biol. 15, 690–698 (2008).

    CAS  Article  Google Scholar 

  6. 6.

    Welsch, J. C. et al. Fatal measles virus infection prevented by brain-penetrant fusion inhibitors. J. Virol. 87, 13785–13794 (2013).

    CAS  Article  Google Scholar 

  7. 7.

    Malvoisin, E. & Wild, F. Contribution of measles virus fusion protein in protective immunity: anti-F monoclonal antibodies neutralize virus infectivity and protect mice against challenge. J. Virol. 64, 5160–5162 (1990).

    CAS  Article  Google Scholar 

  8. 8.

    Fayolle, J., Verrier, B., Buckland, R. & Wild, T. F. Characterization of a natural mutation in an antigenic site on the fusion protein of measles virus that is involved in neutralization. J. Virol. 73, 787–790 (1999).

    CAS  Article  Google Scholar 

  9. 9.

    Avila, M. et al. Molecular determinants defining the triggering range of prefusion F complexes of canine distemper virus. J. Virol. 88, 2951–2966 (2014).

    Article  Google Scholar 

  10. 10.

    Czuppon, P. et al. Success of prophylactic antiviral therapy for SARS-CoV-2: Predicted critical efficacies and impact of different drug-specific mechanisms of action. PLoS Comput Biol. 17, e1008752 (2021).

    CAS  Article  Google Scholar 

Download references


We thank J. S. Orange and S. G. Kernie for their contributions to this study.


The work was supported by grants from the NIH: AI121349, NS091263, and NS105699, AI146980 to M.P., from the French ANR NITRODEP (ANR-13-PDOC-0010-01) to C.M. and from the Region Auvergne Rhone Alpes and LABEX ECOFECT (ANR-11-LABX-0048) of Lyon University within the program “Investissements d'Avenir” (ANR-11-IDEX-0007), operated by the French National Research Agency (ANR) to B.H. The Sharon Golub Fund at Columbia University Irving Medical Center (CUIMC).

Author information



Corresponding authors

Correspondence to Cyrille Mathieu or Matteo Porotto.

Ethics declarations

Competing interests

C.M., A.M., B.H., and M.P. have submitted a provisional on the use of the scFv.

Supplementary information

Rights and permissions

Reprints and Permissions

About this article

Verify currency and authenticity via CrossMark

Cite this article

Mathieu, C., Ferren, M., Harder, O. et al. Single-chain variable fragment antibody constructs neutralize measles virus infection in vitro and in vivo. Cell Mol Immunol (2021).

Download citation


Quick links